170 related articles for article (PubMed ID: 35194034)
21. The emerging role of SPOP protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract][Full Text] [Related]
22. A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells.
Sumara I; Quadroni M; Frei C; Olma MH; Sumara G; Ricci R; Peter M
Dev Cell; 2007 Jun; 12(6):887-900. PubMed ID: 17543862
[TBL] [Abstract][Full Text] [Related]
23. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression.
Wang L; Lin M; Chu M; Liu Y; Ma J; He Y; Wang ZW
EBioMedicine; 2020 Jun; 56():102795. PubMed ID: 32460168
[TBL] [Abstract][Full Text] [Related]
24. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
25. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J
Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330
[TBL] [Abstract][Full Text] [Related]
26. Cullin 3 and Its Role in Tumorigenesis.
Chen RH
Adv Exp Med Biol; 2020; 1217():187-210. PubMed ID: 31898229
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity.
Choo YY; Boh BK; Lou JJ; Eng J; Leck YC; Anders B; Smith PG; Hagen T
Mol Biol Cell; 2011 Dec; 22(24):4706-15. PubMed ID: 22013077
[TBL] [Abstract][Full Text] [Related]
28. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
29. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications.
Yang X; Zhu Q
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360288
[TBL] [Abstract][Full Text] [Related]
30. The Roles of SPOP in DNA Damage Response and DNA Replication.
Maekawa M; Higashiyama S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230
[TBL] [Abstract][Full Text] [Related]
31. The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells.
Lan X; Khandros E; Huang P; Peslak SA; Bhardwaj SK; Grevet JD; Abdulmalik O; Wang H; Keller CA; Giardine B; Baeza J; Duffner ER; El Demerdash O; Wu XS; Vakoc CR; Garcia BA; Hardison RC; Shi J; Blobel GA
Blood Adv; 2019 May; 3(10):1586-1597. PubMed ID: 31126914
[TBL] [Abstract][Full Text] [Related]
32. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
Lutz LM; Pace CR; Arnold MM
J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
[TBL] [Abstract][Full Text] [Related]
33. C-Cbl negatively regulates TRAF6-mediated NF-
Jang HD; Hwang HZ; Kim HS; Lee SY
Cell Mol Biol Lett; 2019; 24():29. PubMed ID: 31123462
[TBL] [Abstract][Full Text] [Related]
34. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
[TBL] [Abstract][Full Text] [Related]
35. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract][Full Text] [Related]
36. ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.
Fan Y; Hou T; Dan W; Zhu Y; Liu B; Wei Y; Wang Z; Gao Y; Zeng J; Li L
Cell Death Differ; 2022 Aug; 29(8):1611-1624. PubMed ID: 35194188
[TBL] [Abstract][Full Text] [Related]
37. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
Lo SC; Hannink M
Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
[TBL] [Abstract][Full Text] [Related]
38. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
39. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
Zhao W; Song Y; Xu B; Zhan Q
Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]